Broadview Ventures

Broadview Ventures is a philanthropic venture capital firm established in 2008 by the Leducq Family Trust, based in Boston, Massachusetts. The firm focuses on accelerating the development of innovative technologies for diagnosing and treating cardiovascular and neurovascular diseases through targeted investments in early-stage ventures. By providing critical funding at pivotal stages, Broadview Ventures aims to bridge the translational gap in medical research, facilitating the progression of scientific advancements into patient care.

The firm's investment strategy encompasses a broad spectrum of stages, including Seed, Early Stage, Series A, Series B, Growth, Late Stage, and Pre-IPO, reflecting a comprehensive approach to nurturing companies at various development phases. Broadview Ventures maintains a strong geographical focus within the United States, aligning with its mission to address health challenges prevalent in the region. The industries of interest are diverse, encompassing Healthcare, Biotechnology, Medical Devices, Pharmaceuticals, and Life Sciences, underscoring the firm's commitment to a holistic approach in the healthcare sector.

In 2024, Broadview Ventures' portfolio companies collectively raised $433 million, demonstrating the firm's effective investment strategy and its role in fostering significant advancements in cardiovascular and stroke treatments. This momentum highlights Broadview Ventures' dedication to supporting innovative solutions that have a meaningful impact on patient outcomes, solidifying its position as a key player in the venture capital landscape focused on healthcare innovation.